3Gialanella B, Bertolinelli M, Monguzzi V, et al. Walking and disability after rehabilitation in patients with cerebellar stroke [ J ]. Minerva Med,2005,96 ( 5 ) :373-378.
4Ye BS, Kim YD, Nam HS, et al. Clinical manifestations of cerebellar infarction according to specific lobular involvement [ J ]. Cerebellum, 2010,9(4) :571-579.
6Hsu ES. A review of granisetron, 5-hydroxytryptamine3 receptor an- tagonists, and other antiemetics[ J ]. Am J Ther, 2010,17 (5) :476- 486.
7Ravikumar K, Sridhar B. Granisetron, an antiemetie drug, and its co- balt complex[ J]. Aeta Crystallogr C ,2010,66( Pt2 ) :m35-39.
8Guichardant M, Thevenon C, Pageaux JF, et al. Basal concentrations of free and esterified monohydroxylated fat- ty acids in human blood platelets[ J]. Clin Chem, 1997, 43 ( 12 ) :2403-2407.
9Luo C, Li T, Zhang C, et al. Therapeutic effect of A1- prostadil in diabetic nephropathy:possible roles of angio- poietin-2 and IL-18[ J]. Cell Physiol Biochem, 2014, 34 (3) :916-928.
10Milcan A, Arslan E, Bagdatoglu OT, et al. The effect of alprostadil on ischemia reperfusion injury of peripheral nerve in rats [ J ]. Pharmacol Res, 2004, 49 ( 1 ) : 67-72.
